Contact: April Hale at

NIHB Statement on FDA Approval of Pfizer Coronavirus Vaccine for Use, Distribution
WASHINGTON, DC—December 14, 2020—The National Indian Health Board (NIHB) offered the following statement from CEO Stacy A. Bohlen on the Federal Drug Administration’s (FDA) recent approval of emergency use authorization to distribute the Pfizer coronavirus vaccine.

“The National Indian Health Board commends the FDA for approving the emergency use authorization (EUA) for the Pfizer coronavirus vaccine. Swift and equitable distribution of this vaccine, and others that may also receive an EUA, will help slow and eventually stop the spread of the virus across our nation and Tribal communities. With Phase One of the vaccine distribution starting this week, NIHB stands ready to work with Operation Warp Speed, the Indian Health Service and Tribal Nations to ensure that the vulnerable and high risk populations in Tribal communities receive a vaccine. We know the task ahead poses many challenges, from tricky distribution logistics to coordinating vaccination events on tight timelines to data reporting every step of the way, however it is more important than ever to meet these challenges head on. Tribes are ready to take on these challenges to protect the health of their citizens.”

Last week, the FDA issued an emergency use authorization on Friday night, and the Centers for Disease Control and Prevention's (CDC) vaccine advisory committee voted on Saturday to administer the Pfizer vaccine to people 16 years and older. CDC Director Robert Redfield approved the recommendation on Sunday.

National Indian Health Board | | 202-507-4070
Visit the NIHB COVID-19 Tribal Resource Center at:

Reach the NIHB COVID-19 Response Team, contact
For media inquiries, contact April Hale at